Treatment for cardiovascular and related diseases

Details Treatment for cardiovascular and related diseases Treatment for cardiovascular and related diseases

2007-02-27

2007-02-27

Bianco, Patricia (Department: 3762)

Surgery

Blood drawn and replaced or treated and returned to body

Constituent removed from blood and remainder returned to body

C604S004010, C422S044000, C210S645000, C210S651000

Reissue Patent

active

09879002

ABSTRACT:
A method for the removal of cholesterol, triglycerides and other lipids from animal plasma, serum or other suitable blood fractions, as a discontinuous flow system, the method comprising withdrawing blood from a subject, separating the required fraction from the blood and mixing with a solvent mixture which extracts the lipids from the fraction, after which the delipidated fraction is recombined with the blood cells and returned to the subject, wherein the solvent extraction step is carried out separately and remote from the subject. The delipidated fraction is washed with a second solvent before being recombined with the blood cells. To ensure that the delipidated fraction is free from all extraction solvent, the fraction is mixed with an absorbent specific for the solvent that is being removed. The preferred absorbent is a macroporous polymeric bead contained in the pores of a sintered glass or plastic sphere, the being capable of absorbing organic molecules from an aqueous solution. By treating the plasma, serum or other suitable blood fraction of a patient by these methods, the blood rheology of a patient with impaired blood circulation can be improved. Further, a rapid regression of coronary atherosclerosis occurs.

REFERENCES:
patent: 3647624 (1972-03-01), Evenson
patent: 3958939 (1976-05-01), Jones
patent: 3983008 (1976-09-01), Shinozaki et al.
patent: 3989466 (1976-11-01), Pan
patent: 4025423 (1977-05-01), Stönner et al.
patent: 4103685 (1978-08-01), Lupien et al.
patent: 4124509 (1978-11-01), Iijima et al.
patent: 4234317 (1980-11-01), Lucas et al.
patent: 4235602 (1980-11-01), Meyer et al.
patent: 4258010 (1981-03-01), Rözsa et al.
patent: 4350156 (1982-09-01), Malchesky et al.
patent: 4391711 (1983-07-01), Jackson et al.
patent: 4399217 (1983-08-01), Holmquist et al.
patent: 4402940 (1983-09-01), Nose et al.
patent: 4435289 (1984-03-01), Breslau
patent: 4463988 (1984-08-01), Bouck et al.
patent: 4481189 (1984-11-01), Prince
patent: 4522809 (1985-06-01), Adamowicz et al.
patent: 4540401 (1985-09-01), Marten
patent: 4540573 (1985-09-01), Neurath et al.
patent: 4581231 (1986-04-01), Purcell et al.
patent: 4591505 (1986-05-01), Prince
patent: 4613501 (1986-09-01), Horowitz
patent: 4615886 (1986-10-01), Purcell et al.
patent: 4643718 (1987-02-01), Marten
patent: 4645512 (1987-02-01), Johns
patent: 4647280 (1987-03-01), Maaskant et al.
patent: 4648974 (1987-03-01), Rosskopf et al.
patent: 4668398 (1987-05-01), Silvis
patent: 4671909 (1987-06-01), Torobin
patent: 4676905 (1987-06-01), Nagao et al.
patent: 4677057 (1987-06-01), Curtiss et al.
patent: 4680320 (1987-07-01), Uku et al.
patent: 4696670 (1987-09-01), Ohnishi et al.
patent: 4775483 (1988-10-01), Mookerjea et al.
patent: 4832034 (1989-05-01), Pizziconi et al.
patent: 4836928 (1989-06-01), Aoyagi et al.
patent: 4879037 (1989-11-01), Utzinger
patent: 4895558 (1990-01-01), Cham
patent: 4908354 (1990-03-01), Seidel et al.
patent: 4909940 (1990-03-01), Horowitz et al.
patent: 4909942 (1990-03-01), Sato et al.
patent: 4923439 (1990-05-01), Seidel et al.
patent: 4935204 (1990-06-01), Seidel et al.
patent: 4966709 (1990-10-01), Nosé et al.
patent: 4970144 (1990-11-01), Fareed et al.
patent: 5026479 (1991-06-01), Bikson et al.
patent: 5080796 (1992-01-01), Nosé et al.
patent: 5089602 (1992-02-01), Isliker et al.
patent: 5112956 (1992-05-01), Tang et al.
patent: 5116307 (1992-05-01), Collins
patent: 5126240 (1992-06-01), Curtiss
patent: 5128318 (1992-07-01), Levine et al.
patent: 5152743 (1992-10-01), Gorsuch et al.
patent: 5187010 (1993-02-01), Parham et al.
patent: 5203778 (1993-04-01), Boehringer et al.
patent: 5211850 (1993-05-01), Shettigar et al.
patent: 5236644 (1993-08-01), Parham et al.
patent: 5256767 (1993-10-01), Salk et al.
patent: 5258149 (1993-11-01), Parham et al.
patent: 5279540 (1994-01-01), Davidson
patent: 5301694 (1994-04-01), Raymond et al.
patent: 5354262 (1994-10-01), Boehringer et al.
patent: 5391143 (1995-02-01), Kensey
patent: 5393429 (1995-02-01), Nakayama et al.
patent: 5401415 (1995-03-01), Rauh et al.
patent: 5401466 (1995-03-01), Foltz et al.
patent: 5418061 (1995-05-01), Parham et al.
patent: 5419759 (1995-05-01), Naficy
patent: 5424068 (1995-06-01), Filip
patent: 5476715 (1995-12-01), Otto
patent: 5484396 (1996-01-01), Naficy
patent: 5496637 (1996-03-01), Parham et al.
patent: 5523096 (1996-06-01), Okarma et al.
patent: 5634893 (1997-06-01), Rishton
patent: 5637224 (1997-06-01), Sirkar et al.
patent: 5652339 (1997-07-01), Lerch et al.
patent: 5679260 (1997-10-01), Boos et al.
patent: 5698432 (1997-12-01), Oxford
patent: 5707673 (1998-01-01), Prevost et al.
patent: 5719194 (1998-02-01), Mann et al.
patent: 5744038 (1998-04-01), Cham
patent: 5753227 (1998-05-01), Strahilevitz
patent: 5853725 (1998-12-01), Salk et al.
patent: 5855782 (1999-01-01), Falkenhagen et al.
patent: 5858238 (1999-01-01), McRea et al.
patent: 5877005 (1999-03-01), Castor
patent: 5885578 (1999-03-01), Salk et al.
patent: 5895650 (1999-04-01), Salk et al.
patent: 5911698 (1999-06-01), Cham
patent: 5916806 (1999-06-01), Salk et al.
patent: 5919369 (1999-07-01), Ash
patent: 5928930 (1999-07-01), Salk et al.
patent: 5948441 (1999-09-01), Lenk et al.
patent: 5962322 (1999-10-01), Kozarsky et al.
patent: 5980478 (1999-11-01), Gorsuch et al.
patent: 6017543 (2000-01-01), Salk et al.
patent: 6022333 (2000-02-01), Kensev
patent: 6037458 (2000-03-01), Hirai et al.
patent: 6039946 (2000-03-01), Strahilevitz
patent: 6193891 (2001-02-01), Kent et al.
patent: 6309550 (2001-10-01), Iverson et al.
patent: 1 271 708 (1990-07-01), None
patent: 1189378 (1998-08-01), None
patent: 29 44 138 (1981-06-01), None
patent: 31 18072 (1982-11-01), None
patent: 32 13390 (1983-10-01), None
patent: 33 10 263 (1984-09-01), None
patent: 0 036 283 (1981-03-01), None
patent: 0 267 471 (1987-10-01), None
patent: 2 571 971 (1984-10-01), None
patent: 127104 (1980-10-01), None
patent: 277303 (1993-10-01), None
patent: 1116396 (1984-09-01), None
patent: 1204224 (1986-01-01), None
patent: 1752187 (1992-07-01), None
patent: WO 88/09345 (1988-12-01), None
patent: WO 95/03840 (1995-02-01), None
patent: WO 9503840 (1995-02-01), None
Agnese, S.T. et al. , “Evaluation of Four Reagents for Delipidation of Serum”, Clinical Biochemistry, 16(2): pp. 98-100 (1983).
Albouz, S. et al. , “Extraction of Plasma Lipids Preserving Antigenic Properties of Proteins and Allowing Quantitation of Gangliosides by Neuraminic Acid Determination”, Ann. Biol. Clin. (Paris) (4ZS), 37(5): pp. 287-290 (1979).
Badimon, J.J. et al. , “High Density Lipoprotein Plasma Fractions Inhibit Aortic Fatty Streaks in Cholesterol-Fed Rabbits”, Laboratory Investigation, vol. 60, No. 3: pp. 455-461 (1989).
Badimon, J.J. et al. , “Regression of Atherosclerotic Lesions by High Density Lipoprotein Plasma Fraction in the Cholesterol-Fed Rabbit”, J. Clinical Investigation, vol. 85, No. 4: pp. 1234-1241 (1990).
Cham, B.E., et al. , “A Solvent System for Delipidation of Plasma or Serum Without Protein Precipitation”, J. of Lipid Research, vol. 17: pp. 176-181 (1976).
Cham, B.E. et al. , “Changes in Electrophoretic Mobilities of α-and β-Lipoproteins as a Result of Plasma Delipidation”, Clinical Chemistry, 22: pp. 305-309 (1976).
Cham, B.E., et al., “Heterogeneity of Lipoprotein B”, Biochemical and Biophysical Research Communications, vol. 103, No. 1: pp. 196-206 (1981).
Cham, B.E., et al. , “Importance of Apolipoproteins in Lipid Metabolism”, Chem. Biol. Interactions, 20: pp. 263-277 (1978).
Cham, B.E. et al. , “In Vitro Partial Relipidation of Apolipoproteins in Plasma”, J. Biol. Chem., 251 (20): pp. 6367-6371 (1976).
Cham, B.E., et al., “Lipid Apheresis in an Animal Model Causes Acute Reduction in Plasma Lipid Concentrations and Mobilisation of Lipid from Liver and Aorta”, Pharmacol. (Life Sci. Adv.)13: pp. 25-32 (1994).
Cham, B.E., et al. , “Lipid Apheresis in an Animal Model Causes In Vivo Changes in Lipoprotein Electrophoretic Pattern

Affiliated with

Also associated with

Rating

Treatment for cardiovascular and related diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for cardiovascular and related diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for cardiovascular and related diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3889004